Market Overview:
The global liquid fibrin sealants market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of surgical procedures, rising demand for minimally invasive surgeries, and technological advancements in the field of fibrin sealants. Based on type, the global liquid fibrin sealants market can be segmented into 2mL/set, 4mL/set, and 10mL/set segments. The 2mL/set segment is expected to account for a major share of the global liquid fibrin sealants market during the forecast period owing to its low price and easy availability. By application, the general surgery segment is expected to account for a major share of the global liquid fibrin sealants market duringthe forecast period owingtoits high adoption rate across various regions worldwide.
Product Definition:
Liquid Fibrin Sealants are blood-clotting agents that are used to seal a wound and stop the bleeding. They are important because they can help to reduce the amount of blood loss and help the wound to heal faster.
2mL/Set:
2mL/Set, it's usage and growth factor in Liquid Fibrin Sealants market? 2 mL (Two drops) of fibrinogen mixed with two units of cryoprecipitate yields a solution that has been used as a sealant for bleeding wounds. It is now commercially available as Plasmanic Coagulant Factor (PCF), which consists of 50% plasma and half-normal human coagulation factors.
4mL/Set:
4mL/Set is a volume unit used for measuring the amount of fibrinogen in units of mL. It is defined as the quantity of fibrinogen that dissolves in 0.5 mL saline solution to give a color reaction at 735 nm when reacted with potassium ferricyanide.
Application Insights:
The general surgery segment dominated the global liquid fibrin sealants market in 2017, accounting for over 30.0% share of the overall revenue. The growing number of general surgeries is one of the major factors contributing to market growth. As per WHO, in 2016, around 1 billion surgical procedures were performed globally which resulted in about 662 thousand deaths annually. Liquid fibrin sealants are used as a substitute for traditional absorbable sutures during various types of general surgeries such as cardiovascular and orthopedic procedures due to their non-contagious nature and reduced risk of infection compared to conventional sutures made from natural or synthetic materials such as polyglycolic acid (PGA), polylactic acid (PLA), or metal wires that require subsequent closure with stitches or staples through small incisions made at approximately 2mm intervals throughout the body surface area involved in surgery.
Regional Analysis:
North America accounted for the largest share of over 35.0% in 2017 owing to the presence of a large number of hospitals and healthcare facilities that use liquid fibrin sealants for various applications. The region is expected to maintain its dominance during the forecast period due to increasing R&D activities by key companies, such as Baxter International; Johnson & Johnson Services, Inc.; and Synthes Pvt. Ltd., among others pertaining to product innovation and development.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global liquid fibrin sealants market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing demand for minimally invasive surgeries.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases such as cancer and cardiovascular diseases is expected to drive the growth of the liquid fibrin sealants market during the forecast period.
- Technological advancements in surgical procedures: The technological advancements in surgical procedures are projected to fuel the growth of the global liquid fibrin sealants market during the forecast period.
- Growing number of product approvals: The growing number of product approvals by regulatory authorities is anticipated to boostthe growthof thismarketduringtheforecastperiod .
Scope Of The Report
Report Attributes
Report Details
Report Title
Liquid Fibrin Sealants Market Research Report
By Type
2mL/Set, 4mL/Set, 10mL/Set
By Application
General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery
By Companies
Baxter, Pfizer, Takeda Pharmaceutical Company, Johnson & Johnson (Ethicon, Inc.), Grifols, CSL Limited, Vivostat, Stryker, Hemarus, Asahi Kasei
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Liquid Fibrin Sealants Market Report Segments:
The global Liquid Fibrin Sealants market is segmented on the basis of:
Types
2mL/Set, 4mL/Set, 10mL/Set
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- Pfizer
- Takeda Pharmaceutical Company
- Johnson & Johnson (Ethicon, Inc.)
- Grifols
- CSL Limited
- Vivostat
- Stryker
- Hemarus
- Asahi Kasei
Highlights of The Liquid Fibrin Sealants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2mL/Set
- 4mL/Set
- 10mL/Set
- By Application:
- General Surgery
- Cardiovascular Surgery
- Wound Management
- Orthopedic Surgery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liquid Fibrin Sealants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liquid Fibrin Sealants are a type of medical adhesive that is used to close wounds. They are made from a mixture of fibrin and other liquids, which helps to form a seal around the wound. This seal prevents fluids from leaking out and helps to prevent infection. Liquid Fibrin Sealants can be applied by doctors or nurses in hospitals or clinics.
Some of the key players operating in the liquid fibrin sealants market are Baxter, Pfizer, Takeda Pharmaceutical Company, Johnson & Johnson (Ethicon, Inc.), Grifols, CSL Limited, Vivostat, Stryker, Hemarus, Asahi Kasei.
The liquid fibrin sealants market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liquid Fibrin Sealants Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liquid Fibrin Sealants Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liquid Fibrin Sealants Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liquid Fibrin Sealants Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liquid Fibrin Sealants Market Size & Forecast, 2020-2028
4.5.1 Liquid Fibrin Sealants Market Size and Y-o-Y Growth
4.5.2 Liquid Fibrin Sealants Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2mL/Set
5.2.2 4mL/Set
5.2.3 10mL/Set
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 General Surgery
6.2.2 Cardiovascular Surgery
6.2.3 Wound Management
6.2.4 Orthopedic Surgery
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liquid Fibrin Sealants Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liquid Fibrin Sealants Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2mL/Set
9.6.2 4mL/Set
9.6.3 10mL/Set
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 General Surgery
9.10.2 Cardiovascular Surgery
9.10.3 Wound Management
9.10.4 Orthopedic Surgery
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2mL/Set
10.6.2 4mL/Set
10.6.3 10mL/Set
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 General Surgery
10.10.2 Cardiovascular Surgery
10.10.3 Wound Management
10.10.4 Orthopedic Surgery
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2mL/Set
11.6.2 4mL/Set
11.6.3 10mL/Set
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 General Surgery
11.10.2 Cardiovascular Surgery
11.10.3 Wound Management
11.10.4 Orthopedic Surgery
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2mL/Set
12.6.2 4mL/Set
12.6.3 10mL/Set
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 General Surgery
12.10.2 Cardiovascular Surgery
12.10.3 Wound Management
12.10.4 Orthopedic Surgery
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2mL/Set
13.6.2 4mL/Set
13.6.3 10mL/Set
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 General Surgery
13.10.2 Cardiovascular Surgery
13.10.3 Wound Management
13.10.4 Orthopedic Surgery
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liquid Fibrin Sealants Market: Competitive Dashboard
14.2 Global Liquid Fibrin Sealants Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter
14.3.2 Pfizer
14.3.3 Takeda Pharmaceutical Company
14.3.4 Johnson & Johnson (Ethicon, Inc.)
14.3.5 Grifols
14.3.6 CSL Limited
14.3.7 Vivostat
14.3.8 Stryker
14.3.9 Hemarus
14.3.10 Asahi Kasei
